相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis
Thi Oanh Bui et al.
EUROPEAN UROLOGY (2022)
PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1+CD8+ Terminal Effector T Cells and Promotes Cancer Development
Yingxia Zheng et al.
JOURNAL OF IMMUNOLOGY (2022)
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization
Landon J. Hansen et al.
SCIENTIFIC REPORTS (2022)
Loss of 9p21 Regulatory Hub Promotes Kidney Cancer Progression by Upregulating HOXB13
Maria Francesca Baietti et al.
MOLECULAR CANCER RESEARCH (2021)
Tumor methionine metabolism drives T-cell exhaustion in hepatocellular carcinoma
Man Hsin Hung et al.
NATURE COMMUNICATIONS (2021)
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
Stanley Gutiontov et al.
SCIENTIFIC REPORTS (2021)
Copy number alteration of the interferon gene cluster in cancer: Individual patient data meta-analysis prospects to personalized immunotherapy
Ali Razaghi et al.
NEOPLASIA (2021)
Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers
Zheng Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Loss of p16: A Bouncer of the Immunological Surveillance?
Kelly E. Leon et al.
LIFE-BASEL (2021)
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
Elio Adib et al.
CLINICAL CANCER RESEARCH (2021)
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
Jeff P. Bruce et al.
NATURE COMMUNICATIONS (2021)
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
Guangchun Han et al.
NATURE COMMUNICATIONS (2021)
Pan-cancer analysis of longitudinal metastatic tumors reveals genomic alterations and immune landscape dynamics associated with pembrolizumab sensitivity
S. Y. Cindy Yang et al.
NATURE COMMUNICATIONS (2021)
Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma
David A. Braun et al.
NATURE MEDICINE (2020)
Association between genetic variants at 9p21 locus with risk of breast cancer: A systematic review and meta-analysis
Hossein Abdeahad et al.
PATHOLOGY RESEARCH AND PRACTICE (2020)
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumab
Scott V. Bratman et al.
NATURE CANCER (2020)
A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma
Niloofar Ghobadi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation (INSPIRE)
Derek L. Clouthier et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Genomic and Functional Approaches to Understanding Cancer Aneuploidy
Alison M. Taylor et al.
CANCER CELL (2018)
Chromosomal instability drives metastasis through a cytosolic DNA response
Samuel F. Bakhoum et al.
NATURE (2018)
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Livnat Jerby-Arnon et al.
CELL (2018)
Biallelic loss of CDKN2A is associated with poor response to treatment in pediatric acute lymphoblastic leukemia
Marcin Braun et al.
LEUKEMIA & LYMPHOMA (2017)
Pan-cancer analysis distinguishes transcriptional changes of aneuploidy from proliferation
Christopher Buccitelli et al.
GENOME RESEARCH (2017)
A germline deletion of 9p21.3 presenting as familial melanoma, astrocytoma and breast cancer: clinical and genetic counselling challenges
Jaime Vengoechea et al.
JOURNAL OF MEDICAL GENETICS (2017)
The immune contexture in cancer prognosis and treatment
Wolf H. Fridman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance
Whijae Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Correlation between chromosome 9p21 locus deletion and prognosis in clinically localized prostate cancer
Erika Aparecida Felix de Barros et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
Genetic variants at 9p21.3 are associated with risk of esophageal squamous cell carcinoma in a Chinese population
Xiaoming Lin et al.
CANCER SCIENCE (2017)
An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies
Maria J. Baker et al.
JOURNAL OF MEDICAL GENETICS (2016)
Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer
Corina Lesseur et al.
NATURE GENETICS (2016)
Chromosomal aberrations and prognosis in patients with concomitant chemoradiotherapy for resected head and neck cancer
Sung-Won Park et al.
ONCOLOGY REPORTS (2016)
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5
Konstantinos J. Mavrakis et al.
SCIENCE (2016)
p16 overexpression and 9p21 deletion are linked to unfavorable tumor phenotype in breast cancer
Patrick Lebok et al.
ONCOTARGET (2016)
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis
Katya Marjon et al.
CELL REPORTS (2016)
Suppressive effects of tumor cell-derived 5 '-deoxy-5 '-methylthioadenosine on human T cells
Frederik C. Henrich et al.
ONCOIMMUNOLOGY (2016)
Biomarkers in Cancer Immunotherapy
Ton N. Schumacher et al.
CANCER CELL (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas
Agusti Alentorn et al.
NEUROLOGY (2015)
Copy number aberrations using multicolour fluorescence in situ hybridization (FISH) for prognostication in non-muscle-invasive bladder cancer (NIMBC)
Hideyasu Matsuyama et al.
BJU INTERNATIONAL (2014)
Genetic polymorphisms in the 9p21 region associated with risk of multiple cancers
Wen-Qing y Li et al.
CARCINOGENESIS (2014)
The metabolite 5′-methylthioadenosine signals through the adenosine receptor A2B in melanoma
Katharina Limm et al.
EUROPEAN JOURNAL OF CANCER (2014)
Copy Number Loss of the Interferon Gene Cluster in Melanomas Is Linked to Reduced T Cell Infiltrate and Poor Patient Prognosis
Peter S. Linsley et al.
PLOS ONE (2014)
New roles for cyclin-dependent kinases in T cell biology: linking cell division and differentiation
Andrew D. Wells et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Protein Arginine Methyltransferase 5 (PRMT5) Inhibition Induces Lymphoma Cell Death through Reactivation of the Retinoblastoma Tumor Suppressor Pathway and Polycomb Repressor Complex 2 (PRC2) Silencing
Jihyun Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Protein arginine methyltransferase 5 is essential for growth of lung cancer cells
Zhongping Gu et al.
BIOCHEMICAL JOURNAL (2012)
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls
Maria N. Timofeeva et al.
HUMAN MOLECULAR GENETICS (2012)
Genome-wide association study identifies novel loci predisposing to cutaneous melanoma
Christopher I. Amos et al.
HUMAN MOLECULAR GENETICS (2011)
9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response
Olivier Harismendy et al.
NATURE (2011)
Crosstalk between Arg 1175 methylation and Tyr 1173 phosphorylation negatively modulates EGFR-mediated ERK activation
Jung-Mao Hsu et al.
NATURE CELL BIOLOGY (2011)
Protein Arginine Methyltransferase 5 Regulates ERK1/2 Signal Transduction Amplitude and Cell Fate Through CRAF
Pedro Andreu-Perez et al.
SCIENCE SIGNALING (2011)
Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies
Axel P. Stevens et al.
JOURNAL OF CHROMATOGRAPHY A (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci
Jin-Xin Bei et al.
NATURE GENETICS (2010)
Genome-wide association study identifies five new breast cancer susceptibility loci
Clare Turnbull et al.
NATURE GENETICS (2010)
New common variants affecting susceptibility to basal cell carcinoma
Simon N. Stacey et al.
NATURE GENETICS (2009)
Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch et al.
NATURE GENETICS (2009)
Genome-wide association study identifies three loci associated with melanoma risk
D. Timothy Bishop et al.
NATURE GENETICS (2009)
Molecular Changes in Primary Breast Tumors and the Nottingham Histologic Score
Rachel E. Ellsworth et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Quantitative analysis of 5′-deoxy-5′-methylthioadenosine in melanoma cells by liquid chromatography-stable isotope ratio tandem mass spectrometry
Axel P. Stevens et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2008)
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Paul Krimpenfort et al.
NATURE (2007)
Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all
Jesus Gil et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Comprehensive analysis of CDKN2A status in microdissected urothelial cell carcinoma reveals potential haploinsufficiency, a high frequency of homozygous co-deletion and associations with clinical phenotype
EJ Chapman et al.
CLINICAL CANCER RESEARCH (2005)
A survey of homozygous deletions in human cancer genomes
C Cox et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Deregulated homeobox gene expression in cancer: Cause or consequence?
C Abate-Shen
NATURE REVIEWS CANCER (2002)
Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma
B Grady et al.
JOURNAL OF UROLOGY (2001)
分享论文
